EU lists rare spinal condition as side-effect of J&J COVID-19 shot

Published by

(Reuters) -Europe’s drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson’s single-dose COVID-19 vaccine. Reports of this serious neurological illness was also at the heart of trial halts in the early stages of development for both AstraZeneca and J&J’s shots, which are based on similar technology. Giving updates on the safety of all coronavirus shots, the European Medicines Agency (EMA) said it was assessing reports of …

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *